Bringing the fundamentals into focus…
Back to Halozyme Therapeutics, Inc.
How Halozyme Therapeutics, Inc. stacks up
HALO · against 129 other Healthcare companies of similar size
Profitability
95/ 100
Near the top of its peers.
Ranked #8 of 130 · scores higher than 92% of peers
Bars: peers in each 10-point band of the profitability score23 peers with a profitability score of 90–100, including HALO · Click a bar to see the companies
Why profitability scores 95?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin, return on assets and return on invested capital, which are stronger than most Healthcare peers.
- a higher return on invested capital: stronger than 88% of peers. Return on invested capital: 22.2% vs peer median 4.7%
- a wider operating margin: stronger than 96% of peers. Operating margin: 35.9% vs peer median 7.1%
- a higher return on assets: stronger than 96% of peers. Return on assets: 16.0% vs peer median 1.7%
Metric by metric
Position: dot = HALO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | HALO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 126 reported | 22.2% | 10.4% | 84% | 33% | |
| Operating marginHigher is better · 126 reported | 35.9% | 14.1% | 95% | 33% | |
| Return on assetsHigher is better · 127 reported | 16.0% | 6.0% | 93% | 33% | |
| Return on equityHigher is better · 123 reported | 173.7% | 11.0% | 100% | Context only | |
| Gross marginHigher is better · 135 reported | 76.3% | 56.1% | 78% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around HALO| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 23.8B USD | 98 | 84 | |
| 5 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 5 | 21.4B USD | 97 | 67 | |
| 5 | 18.5B USD | 97 | 62 | |
| 8 | 89.5B HKD (≈$11.5B) | 95 | 67 | |
| 8 | 14.6B USD | 95 | 59 | |
| 8 | 9.4B USD | 95 | 70 | |
| 8 | 25.8B USD | 95 | 75 | |
| 12 | 14.87T KRW (≈$10.7B) | 94 | 76 | |
| 12 | 27.5B NZD (≈$16.5B) | 94 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score